May 18, 2021 – Revised 08.26.21
July 2021 HCPCS Updates – New and Revised HCPCS Codes
The following information is based on the July 2021 Healthcare Common Procedure Coding System (HCPCS) file. There are several updates that will be effective July 1, 2021. Please keep in mind, the appearance of a HCPCS code is not an indication of coverage by the DME MAC.
This following list contains added HCPCS codes that will be effective July 1, 2021.
HCPCS | DESCRIPTION |
---|---|
J0224 | Injection, lumasiran, 0.5 mg |
J1951 | Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg |
J9348 | Injection, naxitamab-gqgk, 1 mg |
J9353 | Injection, margetuximab-cmkb, 5 mg |
Q5123 | Injection, rituximab-arrx, biosimilar, (riabni), 10 mg |
The following HCPCS code has description/verbiage changes that will be effective July 1, 2021.
HCPCS | DESCRIPTION |
---|---|
J9037 | Injection, belantamab mafodotin-blmf, 0.5 mg |